Division of Syneron Medical Ltd.
Latest From UltraShape Ltd.
The market for aesthetic laser technology has been growing in the past few years, as the public searches for the perfect combination of low-priced, minimally invasive treatments that promise to restore a more youthful appearance. Dermatologists are the key medical practitioners in this field, and although many physicians have been happy to add new, revenue-producing therapies, the lack of extensive clinical data - particularly in the area of laser-liposuction - is a source of concern for a number of doctors.
Pfizer and Zhejiang Hisun Pharmaceutical together invested $545 million to create a Chinese generics joint venture. Dainippon Sumitomo Pharma expanded its cancer pipeline though the acquisition of Boston Biomedical. Driven by a large amount of FOPOs, biopharma financing totaled $1.8 billion in February, while device companies raised $248 million.
A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.
The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
- Medical Devices
- Therapeutic Areas
- Middle East
- Parent & Subsidiaries
- Syneron Medical Ltd.
- Senior Management
Avi Huppert, Pres. & CEO
Zvi Ben David, CFO
- Contact Info
Phone: (972) 49099200
P.O. Box 80 Yoqneam, 20692
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.